<p class="H2"
                                        style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:48pt;text-align:justify;text-indent:-48pt;margin-top:12pt;">
                                        <font class="Bold" style="font-style:normal;font-weight:bold;">
                                            Item 15.     Recent Sales of Unregistered Securities.
                                        </font>
                                    </p>
                                    <p class="Text_flush"
                                        style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">
                                        On August
                                        <font class="nobreak">
                                        </font>
                                        30, 2021, our initial shareholders paid $25,000 to cover certain of our offering
                                        costs in consideration for 1,150,000 founder shares. On November
                                        <font class="nobreak">
                                        </font>
                                        15, 2021, we issued additional 1,006,250 Class B ordinary shares to the initial
                                        shareholders as founder shares for no consideration, resulting in our initial
                                        shareholders holding an aggregate of 2,156,250 founder shares (up to 281,250 of
                                        which are subject to forfeiture by our sponsor depending on the extent to which
                                        the underwriters’ over
                                        <font class="nobreak">
                                            -allotment
                                        </font>
                                        option is exercised) (the “Dividend”). Taking into account the Dividend, founder
                                        shares were sold at $0.012 per share. Each of our initial shareholders is an
                                        accredited investor for purposes of Rule 501 of Regulation D, or otherwise
                                        subject to an exemption from the registration of the sale of securities under
                                        the Securities Act. Such securities were issued in connection with our
                                        organization pursuant to the exemption from registration contained in
                                        Section 4(a)(2) of the Securities Act.
                                    </p>
                                    <p class="Text_flush"
                                        style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">
                                        In addition, our sponsor has committed, pursuant to a written agreement, to
                                        purchase from us an aggregate of 465,000 (or 510,000 if the underwriters’ over
                                        <font class="nobreak">
                                            -allotment
                                        </font>
                                        option is exercised in full) private placement units at $10.00 per unit (for an
                                        aggregate purchase price of $4,650,000 or $5,100,000 if the underwriters’ over
                                        <font class="nobreak">
                                            -allotment
                                        </font>
                                        option is exercised in full). This purchase will take place on a private
                                        placement basis simultaneously with the completion of our initial public
                                        offering. This issuance will be made pursuant to the exemption from registration
                                        contained in Section 4(a)(2) of the Securities Act.
                                    </p>
                                    <p class="Text_flush"
                                        style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">
                                        No underwriting discounts or commissions were paid with respect to such sales.
                                    </p>
                                </div>